Viridian Therapeutics, Inc.
VRDN· Nasdaq
VRDNViridian Therapeutics, Inc.
Filed Nov 13, 2015 · 10-Q · 44 days after period end · 0001171843-15-006329
| Metric | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|
| Revenue | $1.34M | $1.87M | $1.44M |
| Net Income | -$3.15M | -$1.64M | -$939.64K |
| EPS Diluted | -$0.39 | -$0.40 | -$4.70 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Viridian Therapeutics, Inc. · CIK 1590750 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 13, 2015 · 44 d after period end
